Colby Stong

Researchers sought to describe potential differences in the inpatient setting using publicly available data.

Researchers sought to examine the impact of SGLT2 inhibitors on ASCVD and other cardiovascular events in patients with type 2 diabetes.

One of the first clinical trials of ORBCEL-C mesenchymal stromal cells (MSCs) evaluated the safety and effectiveness of this novel therapeutic for ARDS due to COVID-19.

Researchers sought to assess switch rates in patients who initiated use of biologics for psoriasis during a 24-month period.

Investigators assessed the effectiveness of a post-COVID-19 telerehabilitation program offered via web platform and led by a physical therapy professional.

Researchers sought to determine if risk factors for cardiovascular disease and complications changed during different phases of the COVID-19 pandemic.

RECOVERY trial researchers assessed use of higher-dose corticosteroids vs lower-dose CS in inpatients with COVID-19 and hypoxia requiring simple or no oxygen.

Researchers assessed risk factors and their association with atopic dermatitis severity.

Researchers sought to examine the association between atopic dermatitis and herpes zoster infection.

Researchers sought to determine health care utilization trends among children with eczema across sociodemographic factors.

Researchers sought to evaluate responses to bimekizumab therapy over 3 years in patients with moderate-to-severe plaque psoriasis.

Researchers evaluated local recurrence rate following desmoplastic melanoma excision.

Researchers sought to evaluate the effect of vitamin D supplementation on psoriasis severity during the winter.

Researchers tested wastewater collected during the COVID-19 pandemic to assess the value of using RT-PCR assays targeting respiratory viral genomes on wastewater.

Researchers sought to examine immune-mediated and androgen-mediated skin diseases associated with metformin.

Researchers compared patients’ COVID-19 pneumonia outcomes then using therapeutic anticoagulation vs high- or standard-dose prophylactic anticoagulation.

Researchers sought to compare clinical outcomes of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis treated with plasmapheresis first vs intravenous immunoglobulin.

Researchers sought to evaluate implementation of protocolized biologic dose reduction in psoriasis.

Researchers sought to assess the efficacy of upadacitinib monotherapy for the treatment of alopecia areata.

Investigators assessed changes in the circulation of respiratory viruses during multiple early waves of the COVID-19 pandemic.

Researchers assessed how improvements in clinical responses are associated with improvements in patient-reported outcomes and quality of life in atopic dermatitis.

Researchers identified cytokines and other inflammatory blood biomarkers that could be used to predict and distinguish between SARS-CoV-2 vs influenza infection.

Researchers assessed the prevalence, efficacy, and safety of narrowband ultraviolet B phototherapy.

Researchers evaluated disease control in patients with moderate-to-severe atopic dermatitis.

Researchers assessed the accuracy of a traditional statistical risk factor-based model versus machine learning in predicting the 5-year probability of biologic discontinuation.

Researchers studied the epidemiology of COVID-19 viral and symptom rebound in patients with acute COVID-19 infection who received nirmatrelvir plus ritonavir.

Researchers evaluated the use of anti-interleukin (IL)-17A biologics among patients with moderate to severe psoriasis.

A systematic review and meta-analysis assessed the duration of viable virus shedding and PCR positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract.

Researchers sought to characterize the evolution of blue nevi and assess the need for monitoring.

Researchers sought to determine the prevalence and bidirectional associations of atopic dermatitis with food sensitivity and food allergies.